We are always pleased to hear from members of the press interested in what we’re doing at Acurable. The information and resources on this page are yours to use (please take note of our branding and trademark guidelines), or get in touch with us directly at for a more in-depth discussion.

About Acurable

The company

  • Acurable is a venture-backed, fast growing medical devices company with offices in London and Seville.
  • We create accurate and user-friendly wearable medical devices intended to be used by patients at home.

The AcuPebble technology

  • Our award-winning, patented technology enables for the first time non-invasive, continuous and accurate monitoring of breathing biosignals.
  • It is a breakthrough in respiratory medicine and the product of more than 10 years’ research at Imperial College London by Acurable’s founder, Professor Esther Rodriguez Villegas.
  • The first two applications of the technology are in sleep apnoea diagnosis and clinical research monitoring of patients.
  • In parallel, Acurable continues its R&D efforts to complete and launch additional products that will fundamentally improve other areas of healthcare such as the prevention of Sudden Unexpected Death in Epilepsy (SUDEP) and the management of COPD exacerbations.


AcuPebble SA100 is the first medical device to obtain the CE mark for the automated diagnosis of Obstructive Sleep Apnoea.

  • It offers a clinically validated automated diagnosis
  • It is comfortable and easy to use by patients at home
  • It is cost-efficient and a reliable home sleep test

Key facts

  • Founded in 2016 by Prof. Esther Rodriguez-Villegas, Emilio Sanz Pereiras and Dr Anas Imtiaz (founder bios).
  • Based on over 10 years of research at Imperial College London (more about our story).
  • Winner of XPrize in 2014, the most prestigious prize in the medical technology industry.
  • First product focused on improving diagnosis of sleep apnoea (more about AcuPebble SA100).
  • Raised £2.1m investment from VCs Kindred Capital and Alma Mundi Ventures (2017).
  • Awarded two Innovate UK grants worth £1.4m (2019).
  • Obtained CE mark as class IIa medical device (2020).

Media assets

Logo without icon (EPS + PNG)


R255 G255 B255
Dark grey
R47 G47 B47
Mustard yellow
R243 G186 B0
Dark blue
R0 G67 B102

Trademark guidelines

When referencing our company brand and products in writing:

  • Acurable is always written as a single word with an uppercase A.
  • AcuPebble® is always written as a single word with an uppercase A and P, followed by the Registered trademark symbol in superscript format (®).

Stay updated about the company news with our newsletter